Glucagon-like peptide-1 (GLP-1) analogues
- Name
- Glucagon-like peptide-1 (GLP-1) analogues
- Accession Number
- DBCAT004598
- Description
Not Available
- ATC Classification
- Drugs
Drug Drug Description Exenatide A GLP-1 agonist used in the management of type 2 diabetes mellitus. Liraglutide A GLP-1 analog used in the management of type 2 diabetes mellitus and prevention of cardiovascular complications associated with diabetes. Albiglutide A GLP-1 agonist used to manage type 2 diabetes mellitus. Dulaglutide A GLP-1 agonist used to manage type 2 diabetes mellitus. Lixisenatide A GLP-1 receptor agonist used for the management of type 2 diabetes mellitus. Semaglutide A glucagon-like peptide 1 receptor agonist used to improve glycemic control in type 2 diabetes mellitus, treat obesity, and reduce the risk of major adverse cardiovascular events in selected adults. Beinaglutide Beinaglutide is under investigation in clinical trial NCT03829891 (Study for Beinaglutide Versus Glargine Therapy in Glycemic Variability of Type 2 Diabetes Mellitus). - Drugs & Drug Targets